These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 412104)

  • 21. [Experimental methods used in the evaluation of antitumor action of new agents].
    Graczyk J; Robak T
    Postepy Hig Med Dosw; 1978; 32(3):391-403. PubMed ID: 714827
    [No Abstract]   [Full Text] [Related]  

  • 22. Experimental evaluation of antitumor drugs in the USA and USSR and clinical correlations.
    Natl Cancer Inst Monogr; 1980 Dec; (55):1-179. PubMed ID: 7010179
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical predictivity of transplantable tumor systems in the selection of new drugs for solid tumors: rationale for a three-stage strategy.
    Staquet MJ; Byar DP; Green SB; Rozencweig M
    Cancer Treat Rep; 1983 Sep; 67(9):753-65. PubMed ID: 6883351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Soviet-American cooperation in experimental and clinical chemotherapy from 1972 to 1979].
    Peredovchikova NI; Kiselev AV; Puchkov IuI; Komarova LE; Gorbunova VA
    Vopr Onkol; 1980; 26(12):3-6. PubMed ID: 7008350
    [No Abstract]   [Full Text] [Related]  

  • 25. Working session report: laboratory of toxicology.
    Dixon RL
    Cancer Chemother Rep 3; 1972 May; 3(1):63-7. PubMed ID: 4626120
    [No Abstract]   [Full Text] [Related]  

  • 26. Design and evaluation of combination chemotherapy trials in experimental animal tumor systems.
    Corbett TH; Griswold DP; Wolpert MK; Venditti JM; Schabel FM
    Cancer Treat Rep; 1979 May; 63(5):799-801. PubMed ID: 455319
    [No Abstract]   [Full Text] [Related]  

  • 27. Screening of Philippine medicinal plants for anticancer agents using CCNSC Protocols.
    Masilungan VA; Vadlamudi S; Goldin A
    Cancer Chemother Rep 2; 1971 Apr; 2(1):135-40. PubMed ID: 5109412
    [No Abstract]   [Full Text] [Related]  

  • 28. Adequacies and inadequacies in assessing murine toxicity data with antineoplastic agents.
    Guarino AM; Rozencweig M; Kline I; Penta JS; Venditti JM; Lloyd HH; Holzworth DA; Muggia FM
    Cancer Res; 1979 Jun; 39(6 Pt 1):2204-10. PubMed ID: 445419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Value of experimental results in clinical tumor chemotherapy (author's transl)].
    Somfai-Relle S; Sugár J
    Arch Geschwulstforsch; 1980; 50(2):132-40. PubMed ID: 7436697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The new NCI screen and its implications for clinical evaluation.
    Goldin A; Venditti JM
    Recent Results Cancer Res; 1980; 70():5-20. PubMed ID: 7355249
    [No Abstract]   [Full Text] [Related]  

  • 31. Advances in the clinical development of antiepileptic drugs.
    Porter RJ; Hessie BJ; Cereghino JJ; Gladding GD; Kupferberg HJ; Scoville B; White BG
    Fed Proc; 1985 Jul; 44(10):2645-9. PubMed ID: 3891417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Collection and presentation of combination data.
    Mancher RR
    Cancer Chemother Rep 2; 1974 Mar; 4(1):167-80. PubMed ID: 4826496
    [No Abstract]   [Full Text] [Related]  

  • 33. A prospective screening program: current screening and its status.
    Goldin A; Venditti JM
    Recent Results Cancer Res; 1981; 76():176-91. PubMed ID: 7232850
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical test methods for antitumor drugs in the U.S.S.R.
    Garin AM; Lichinitser MR
    Natl Cancer Inst Monogr; 1977 Mar; (45):227-33. PubMed ID: 337153
    [No Abstract]   [Full Text] [Related]  

  • 35. [Experimental methodology for the selection of potential anticancer agents].
    Pérez Mínguez F; Llombart Bosch A
    Rev Esp Oncol; 1982; 29(4):593-602. PubMed ID: 6927364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preclinical toxicologic evaluation of dianhydrogalactitol in dogs and monkeys.
    Folk RM; Pavkov KL; Thake DC
    Cancer Treat Rep; 1976 Oct; 60(10):1585-9. PubMed ID: 828520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Teratology.
    Staples RE
    J Assoc Off Anal Chem; 1979 Jul; 62(4):833-9. PubMed ID: 500534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The National Cancer Institute's Natural Products Antineoplastic Development Program.
    Douros J; Suffness M
    Recent Results Cancer Res; 1980; 70():21-44. PubMed ID: 7355247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical toxicology studies of 4-ipomeanol: a novel candidate for clinical evaluation in lung cancer.
    Smith AC; Barrett D; Stedham MA; el-Hawari M; Kastello MD; Grieshaber CK; Boyd MR
    Cancer Treat Rep; 1987 Dec; 71(12):1157-64. PubMed ID: 3690525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The NCI Developmental Therapeutics Program.
    Collins JM
    Clin Adv Hematol Oncol; 2006 Apr; 4(4):271-3. PubMed ID: 16728938
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.